Some ideas concerning the mode of action of radioprotective agents.
D000311:Adrenal Glands / Q000378:metabolism; D000818:Animals; D003345:Corticosterone / Q000378:metabolism; D003538:Cystamine / Q000494:pharmacology; D003543:Cysteamine / Q000494:pharmacology; D003900:Desoxycorticosterone / Q000378:metabolism; D004983:Ethanolamines / Q000494:pharmacology; D008099:Liver / Q000187:drug effects / Q000201:enzymology; D008297:Male; D008623:Mercaptoethanol; D012157:Mononuclear Phagocyte System / Q000187:drug effects / Q000528:radiation effects; D010090:Oxidoreductases, O-Demethylating / Q000037:antagonists & inhibitors; D010587:Phagocytosis / Q000187:drug effects / Q000528:radiation effects; D010913:Pituitary-Adrenal System / Q000187:drug effects / Q000528:radiation effects; D011837:Radiation-Protective Agents / Q000494:pharmacology*; D051381:Rats; D013250:Steroid Hydroxylases / Q000037:antagonists & inhibitors
D004983:Ethanolamines; D011837:Radiation-Protective Agents; D003900:Desoxycorticosterone; D003543:Cysteamine; D008623:Mercaptoethanol; D010090:Oxidoreductases, O-Demethylating; D013250:Steroid Hydroxylases; D003538:Cystamine; D003345:Corticosterone